A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FACES, talks with Michael See, MS, CDCES, ACSM-CEP, NBC-HWC, about tips for exercise for people living with diabetes. Weiner: ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Eli Lilly's new oral weight loss pill, orforglipron, shows promise in Phase 3 trials, offering a convenient alternative to ...

A once-daily oral GLP-1 conferred greater reductions in HbA1c and body weight than placebo among adults with type 2 diabetes, ...

Obesity and diabetes often overshadow liver health, yet the liver is significantly stressed in both conditions, potentially ...

Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...

Older women who stayed on a reduced-calorie Mediterranean diet, walked and did resistance training for three years improved ...

Have you or someone you know been diagnosed with type 2 diabetes? We've got fantastic news! More and more people are ...

Health and Human Services Secretary Robert F. Kennedy Jr. spoke with CBS News in an exclusive interview. Here are some highlights.

In the search for sustainable weight loss, one diet strategy is starting to stand out from the rest. A new yearlong clinical ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are ...